We are live on ! Find out more
MDVL

MedAvail Holdings, Inc. Common Stock
MDVL

Delisted

MDVL was delisted on the 12th of February, 2024.

Back to rankings

30 hedge funds and large institutions have $20.6M invested in MedAvail Holdings, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6% less funds holding

Funds holding: 32 → 30 (-2)

14% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 7

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

62% less capital invested

Capital invested by funds: $53.9M → $20.6M (-$33.3M)

Holders
30
Holders Change
-2
Holders Change %
-6.25%
% of All Funds
0.48%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
6
Reduced
7
Closed
4
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
-$451K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$18.5K
2
TSS
Two Sigma Securities
New York
+$7.4K
3
Renaissance Technologies
Renaissance Technologies
New York
+$7.31K
4
TRCT
Tower Research Capital (TRC)
New York
+$2.07K
5
NA
NewEdge Advisors
Louisiana
+$1.73K

Top Sellers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$284K
2
PVI
Pura Vida Investments
New York
-$220K
3
Man Group
Man Group
United Kingdom
-$25K
4
Verition Fund Management
Verition Fund Management
Connecticut
-$8K
5
JIC
Joel Isaacson & Co
New York
-$576
Name Holding Trade Value Shares
Change 		Change in
Stake
RG
1
Redmile Group
California
$10.4M – – –
AWGLSCP
2
ABG-WTT Global Life Science Capital Partners
Hong Kong
$4.51M – – –
Alyeska Investment Group
3
Alyeska Investment Group
Illinois
$1.97M -$284K -9,878 -7%
ABG
4
Ally Bridge Group
New York
$1.77M – – –
CI
5
Cigna Investments
Connecticut
$716K – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$317K +$1.04K +36 +0.2%
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
$300K – – –
DM
8
Deerfield Management
New York
$251K – – –
PVI
9
Pura Vida Investments
New York
$99.5K -$220K -7,647 -54%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$55K -$259 -9 -0.2%
Millennium Management
11
Millennium Management
New York
$52K +$18.5K +644 +23%
BlackRock
12
BlackRock
New York
$50.1K +$1.06K +37 +1%
State Street
13
State Street
Massachusetts
$28.6K – – –
APP
14
Alpha Paradigm Partners
Illinois
$17K – – –
Renaissance Technologies
15
Renaissance Technologies
New York
$16K +$7.31K +254 +32%
Northern Trust
16
Northern Trust
Illinois
$12.9K – – –
JIC
17
Joel Isaacson & Co
New York
$5.62K -$576 -20 -5%
BP
18
BBR Partners
New York
$4.57K – – –
US Bancorp
19
US Bancorp
Minnesota
$3.95K – – –
TSS
20
Two Sigma Securities
New York
$3.85K +$7.4K +257 New
Charles Schwab
21
Charles Schwab
California
$3.56K – – –
TRCT
22
Tower Research Capital (TRC)
New York
$3K +$2.07K +72 +61%
UBS Group
23
UBS Group
Switzerland
$1.85K +$1.3K +45 +58%
Fidelity Investments
24
Fidelity Investments
Massachusetts
$1.83K – – –
Morgan Stanley
25
Morgan Stanley
New York
$1.6K -$576 -20 -16%
1
2

MDVL Hedge Fund Activity: Q4 2022 in Review

30 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in MedAvail Holdings, Inc. Common Stock (MDVL) for Q4 2022, worth a combined $20.6M — down 62% from $53.9M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of MDVL and 2 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 6 added.

The largest buyer was Millennium Management, adding an estimated $18.5K. The largest seller was Alyeska Investment Group, cutting an estimated $284K.

  • 30 institutional investors held MedAvail Holdings, Inc. Common Stock (MDVL) as of Q4 2022, down from 32 in Q3 2022.
  • Funds reported $20.6M of MedAvail Holdings, Inc. Common Stock stock for Q4 2022, down 62% quarter-over-quarter.
  • 2 funds opened new MedAvail Holdings, Inc. Common Stock positions in Q4 2022 and 4 closed out, a net change of -2 holders.
  • The largest MedAvail Holdings, Inc. Common Stock buyer in Q4 2022 was Millennium Management, an estimated $18.5K added.
  • The largest MedAvail Holdings, Inc. Common Stock seller in Q4 2022 was Alyeska Investment Group, an estimated $284K sold.

Based on aggregated 13F filings for Q4 2022.